Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to human programmed death receptor PD-1

Antibodies to human programmed death receptor PD-1

US Patent 11117961 · Granted Sep 14, 2021

Estimated economic value: $141,891,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LTBP complex-specific inhibitors of TGF-beta 1 and uses thereof2025
TGFβ antibodies, methods and uses2025
Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors2025
Combining CD27 agonists and immune checkpoint inhibition for immune stimulation2024
Tissue factor pathway inhibitor antibodies and uses thereof2024
Method of treating IgA nephropathy by administering altered antibodies which bin2024
Isoform-selective TGFB1 inhibitors and use thereof2024
Methods for performing ex vivo diagnostic tests for the presence of a proliferat2024
TGFβ1-binding immunoglobulins and use thereof2023
Tissue factor pathway inhibitor antibodies and uses thereof2023
Methods for using anti-myostatin antibodies2022
Isoform-selective TGFβ1 inhibitors and use thereof2021